Body mass index and risk of malignant lymphoma in Scandinavian men and women.
暂无分享,去创建一个
H. Adami | H. Johnsen | E. Chang | M. Melbye | H. Hjalgrim | B. Glimelius | M. Åkerman | K. Smedby | E. Tani
[1] H. Adami,et al. Ultraviolet radiation exposure and risk of malignant lymphomas. , 2005, Journal of the National Cancer Institute.
[2] E. Negri,et al. Non‐Hodgkin's lymphoma and hepatitis C virus: A case‐control study from northern and southern Italy , 2004, International journal of cancer.
[3] M. Forrest,et al. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] J Kaldor,et al. Use of the WHO lymphoma classification in a population-based epidemiological study. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] S. Wen,et al. Association of obesity and cancer risk in Canada. , 2004, American journal of epidemiology.
[6] S. Sukpanichnant. Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. , 2004, Human pathology.
[7] R. Hoover,et al. Obesity and cancer risk among white and black United States veterans , 2004, Cancer Causes & Control.
[8] E. Holly,et al. Expert Review of Non-Hodgkin’s Lymphomas in a Population-Based Cancer Registry , 2004, Cancer Epidemiology Biomarkers & Prevention.
[9] D. Berrigan,et al. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. , 2003, Annual review of medicine.
[10] J. Coebergh,et al. No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands) , 2003, Cancer Causes & Control.
[11] F. Rasmussen,et al. Importance of smoking habits for longitudinal and age-matched changes in body mass index: a cohort study of Swedish men and women. , 2003, Preventive medicine.
[12] S. Bentley. WHO Classification of Tumours: Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[13] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[14] J. Cerhan,et al. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[15] J. Cerhan,et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. , 2002, American journal of epidemiology.
[16] Harri Vainio,et al. Overweight, obesity, and cancer risk. , 2002, The Lancet. Oncology.
[17] A. Martí,et al. Obesity and immunocompetence , 2002, European Journal of Clinical Nutrition.
[18] D. Hossfeld. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .
[19] Harri Vainio,et al. Weight control and physical activity in cancer prevention , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[20] B. Nathwani,et al. Diffuse Large B-cell Lymphoma: A Clinicopathologic Analysis of 444 Cases Classified According to the Updated Kiel Classification , 2002, Leukemia & lymphoma.
[21] A. Martí,et al. Obesity and immune function relationships , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[22] L. Bernstein,et al. Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[24] S. Perkins,et al. Effects of calorie restriction on thymocyte growth, death and maturation. , 2000, Carcinogenesis.
[25] T. Powles,et al. HIV-associated Hodgkin's disease , 2000, International journal of STD & AIDS.
[26] W. Willett,et al. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. , 1999, Journal of the National Cancer Institute.
[27] E. Holly,et al. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. , 1999, American journal of epidemiology.
[28] J. Coebergh,et al. The rise in incidence of lymphomas in Europe 1985-1992. , 1999, European journal of cancer.
[29] Y. Ko,et al. REAL classification of malignant lymphomas in the republic of korea , 1998, Cancer.
[30] L. Tryggvadottir,et al. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] K. Flegal,et al. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). , 1997, Obesity research.
[32] B. Nathwani,et al. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .
[33] A. R. Frisancho. Physical Status: The Use and Interpretation of Anthropometry , 1996, The American Journal of Clinical Nutrition.
[34] S. Greenland,et al. Simulation study of confounder-selection strategies. , 1993, American journal of epidemiology.
[35] M. Gail,et al. Increasing incidence of non-Hodgkin's lymphoma. , 1993, Seminars in hematology.
[36] T. Fears,et al. Non-Hodgkin's lymphoma time trends: United States and international data. , 1992, Cancer research.
[37] P. Banks. Changes in diagnosis of non-Hodgkin's lymphomas over time. , 1992, Cancer research.
[38] P. Hartge,et al. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. , 1992, Cancer research.
[39] R. Hoover. Lymphoma risks in populations with altered immunity--a search for mechanism. , 1992, Cancer research.
[40] R. Shapiro,et al. Primary immunodeficiencies: genetic risk factors for lymphoma. , 1992, Cancer research.
[41] G. I. Obrams,et al. Time Trends and Pathological Classification: A Summary , 1992 .
[42] R. Hoover,et al. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[43] F. d'Amore,et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas , 1991 .
[44] F. Alexander,et al. Epidemiological evidence for the 'two-disease hypothesis' in Hodgkin's disease. , 1991, International journal of epidemiology.
[45] F. Lo Coco,et al. Immune-deficiency in Hodgkin's disease (HD): a study of patients and healthy relatives in families with multiple cases. , 1988, European journal of cancer & clinical oncology.
[46] Gutensohn Nm. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the "two-disease hypothesis". , 1982 .
[47] B. Macmahon. Epidemiology of Hodgkin's disease. , 1966, Cancer research.
[48] L. Bernstein,et al. CHAPTER 9 – Obesity and Cancer Risk , 2006 .
[49] H. Adami,et al. A prospective study of obesity and cancer risk (Sweden) , 2004, Cancer Causes & Control.
[50] S. Franceschi,et al. Hepatitis B and C viruses and Hodgkin lymphoma: a case-control study from Northern and Southern Italy. , 2004, Haematologica.
[51] J. Vose,et al. Update on epidemiology and therapeutics for non-Hodgkin's lymphoma. , 2002, Hematology. American Society of Hematology. Education Program.
[52] I. Aurer,et al. The World Health Organization classification of lymphomas. , 2002, Croatian medical journal.
[53] K. Naresh,et al. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[54] The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. , 2000, Pathology international.
[55] James Olen Armitage,et al. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. , 1997, Blood.
[56] J. Olsen,et al. Obesity and cancer risk: a Danish record-linkage study. , 1994, European journal of cancer.
[57] A. Levine,et al. Lymphoma complicating immunodeficiency disorders. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[58] R. Badwe,et al. Timing of breast cancer surgery during the menstrual cycle. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[59] F. d'Amore,et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. , 1991, European journal of cancer.
[60] C. la Vecchia,et al. The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case-control study. , 1989, Leukemia research.
[61] E. Nera,et al. Dietary restriction, cell proliferation and carcinogenesis: a preliminary study. , 1988, Cancer letters.
[62] M. Singer,et al. Nutritional Epidemiology , 2020, Definitions.
[63] N. Gutensohn. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the "two-disease hypothesis". , 1982, Cancer treatment reports.